<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical and laboratory studies were carried out in 38 pregnant women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Increased functional activity of platelets and decreased protein-producing function of the placenta were observed starting from the early terms of gestation </plain></SENT>
<SENT sid="2" pm="."><plain>These disorders were followed by the development of hypercoagulation in the plasma component of hemostasis, appearance of intravascular blood clotting markers, and inhibition of AT III and protein C </plain></SENT>
<SENT sid="3" pm="."><plain>This led to the progress of disorders in the microcirculatory bed, fetoplacental insufficiency, decrease in trophoblastic beta1-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> level, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0005039'>hypoxia</z:mp>, and fetal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> accelerated this process </plain></SENT>
<SENT sid="5" pm="."><plain>Measurements of trophoblastic beta1-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> every 2 weeks help to diagnose fetoplacental disorders, predict the course of pregnancy, and evaluate the efficiency of drug therapy </plain></SENT>
</text></document>